About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Th
tyrosine hydroxylase
MGI:98735
64 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Cox4i2tm1Hutt/Cox4i2tm1.1Jlob
Thtm1(cre)Te/Th+
involves: 129X1/SvJ * C57BL/6
abnormal physiological response to hypoxia J:302384
Dbhtm2(Th)Rpa/Dbh+
Thtm1Rpa/Thtm1Rpa
involves: 129S7/SvEvBrd
abnormal nervous system physiology J:30404
adipsia J:30404
aphagia J:30404
decreased body size J:30404
decreased body weight J:30404
decreased brain size J:30404
decreased dopamine level J:30404
decreased locomotor activity J:30404
decreased stereotypic behavior J:30404
hunched posture J:30404
poor grooming J:30404
premature death J:30404
weight loss J:30404
Dbhtm2(Th)Rpa/Dbh+
Thtm1Rpa/Thtm1Rpa
involves: 129S7/SvEvBrd * C57BL/6J
abnormal gait J:58125
akinesia J:58125
catalepsy J:58125
decreased compensatory feeding amount J:58125
decreased food intake J:58125
decreased locomotor activity J:58125
hunched posture J:58125
hyperactivity J:58125
hyporesponsive to tactile stimuli J:58125
impaired behavioral response to addictive substance J:58125
impaired coordination J:58125
increased stereotypic behavior J:58125
premature death J:58125
Dbhtm2(Th)Rpa/Dbh+
Thtm5Rpa/Thtm5Rpa
involves: 129S4/SvJaeSor
abnormal avoidance learning behavior J:154773
decreased dopamine level J:154773
Dbhtm2(Th)Rpa/Dbh+
Thtm5Rpa/Thtm5Rpa
involves: 129S4/SvJaeSor * C57BL/6
abnormal eating behavior J:110806
abnormal motor capabilities/coordination/movement J:110806
abnormal postnatal growth J:110806
decreased body weight J:110806
decreased compensatory feeding amount J:110806
decreased dopamine level J:110806
hyperactivity J:110806
impaired coordination J:110806
increased food intake J:110806
increased thigmotaxis J:110806
normal mortality/aging J:110806
Dbhtm2(Th)Rpa/Dbh+
Thtm5Rpa/Thtm5Rpa
involves: 129S4/SvJaeSor * C57BL/6
aphagia J:110806
bradykinesia J:110806
decreased body weight J:110806
decreased dopamine level J:110806
decreased locomotor activity J:110806
premature death J:110806
weight loss J:110806
Grprtm1Jfb/Grprtm1Jfb
Slc17a6tm1Kldr/Slc17a6tm1Kldr
Thtm1(cre)Te/Th+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
excessive scratching J:167752
Med22tm1a(EUCOMM)Hmgu/Med22+
Thtm1(cre)Te/Th+
involves: 129X1/SvJ * C57BL/6N
normal renal/urinary system phenotype J:300239
Med22tm1a(EUCOMM)Hmgu/Med22tm1a(EUCOMM)Hmgu
Thtm1(cre)Te/Th+
involves: 129X1/SvJ * C57BL/6N
preweaning lethality, complete penetrance J:300239
Ndufa4l2tm1.1Jlob/Ndufa4l2tm1.2Jlob
Thtm1(cre)Te/Th+
involves: 129S/Sv * 129X1/SvJ * C57BL/6NCrl * C57BL/6NTac
abnormal physiological response to hypoxia J:302384
Or51e2tm3.1Mom/Or51e2tm3.1Mom
Thtm1(cre)Te/?
involves: 129X1/SvJ * C57BL/6
abnormal type I cell of carotid body physiology J:350385
Psmc1tm1Maye/Psmc1tm1.1Maye
Thtm1(cre)Te/Th+
involves: 129X1/SvJ * CD-1
abnormal noradrenaline level J:138991
alpha-synuclein inclusion body J:138991
decreased body size J:138991
decreased dopamine level J:138991
gliosis J:138991
neuron degeneration J:138991
postnatal lethality J:138991
Psmc1tm1Maye/Psmc1tm1Maye
Thtm1(cre)Te/Th+
involves: 129X1/SvJ * CD-1
abnormal noradrenaline level J:138991
alpha-synuclein inclusion body J:138991
decreased body size J:138991
decreased dopamine level J:138991
gliosis J:138991
neuron degeneration J:138991
postnatal lethality, complete penetrance J:138991
Sdhdtm1Jlob/Sdhdtm2Jlob
Thtm1(cre)Te/Th+
involves: 129S1/Sv * 129X1/SvJ
abnormal adrenal chromaffin cell morphology J:186713
abnormal dopaminergic neuron morphology J:186713
bradykinesia J:186713
decreased birth body size J:186713
decreased dopamine level J:186713
decreased locomotor activity J:186713
decreased neuron number J:186713
loss of dopaminergic neurons J:186713
normal neoplasm J:186713
oxidative stress J:186713
premature death J:186713
Slc17a6tm1Kldr/Slc17a6tm1Kldr
Thtm1(cre)Te/Th+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
abnormal pain threshold J:167752
decreased chemically-elicited antinociception J:167752
excessive scratching J:167752
normal homeostasis/metabolism phenotype J:167752
increased pruritus J:167752
increased thermal nociceptive threshold J:167752
mixed cellular infiltration to dermis J:167752
skin lesions J:167752
thick epidermis J:167752
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
Thtm1(cre)Te/Th+
involves: 129X1/SvJ * C57BL/6 * FVB/N
adrenal gland hyperplasia J:186696
increased metastatic potential J:186696
increased neuroblastoma incidence J:186696
Thtm1Srt/Thtm1Srt
Tyrc/Tyrc
involves: 129S2/SvPas * C57BL/6J * ICR
abnormal adrenaline level J:54692
abnormal noradrenaline level J:54692
decreased dopamine level J:54692
prenatal lethality, complete penetrance J:54692
Thtm2Te/Thtm2Te
involves: 129X1/SvJ * C57BL/6
bradykinesia J:93552
decreased body size J:93552
decreased dopamine level J:93552
decreased noradrenaline level J:93552
increased serotonin level J:93552

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory